Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:21 PM
Ignite Modification Date:
2025-12-24 @ 10:21 PM
NCT ID:
NCT01875835
Eligibility Criteria:
Inclusion Criteria:
* Age: 18-75 years
* Acute MI with ST-segment elevation, within 12 hours from symptoms onset.
* Length of culprit lesion≤25mm.
* Vessel size in between 2.5 and 4.0 mm.
* Signed patient informed consent.
Exclusion Criteria:
* Prior administration of thrombolytic therapy.
* Cardiogenic shock.
* Renal failure (Crea≥2.0mg/dL).
* Recent major bleeding.
* Allergy to heparin, aspirin, clopidogrel, everolimus, the polymer components of the Xience V stent, stainless steel, or contrast media.
* Left main disease
* Multi-vessel lesion
* Other hemodynamically significant lesion(s) is present in the infarct vessel (or side branches)
* Angiography demonstrates the infarct lesion to be at the site of a previously implanted stent or in bypass grafts.
* No suitable anatomy for OCT scan.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT01875835
Study Brief:
Protocol Section:
NCT01875835